What is

PathologyWatch?

Revolutionizing Pathology for Dermatologists

PathologyWatch is working with dermatology practices like yours to manage your pathology workflow using a digital model.

This helps to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. It has been shown to streamline clinical workflow by interfacing directly with your EMR of choice, resulting in brilliantly optimized joining of clinical decision-making and patient care.

PathologyWatch Mission

To preserve and extend life for patients while reducing the cost of healthcare.

Our Awesome Team

Dan Lambert

Chief Executive Officer | Co-Founder

Dan Lambert received a degree from BYU in Computer Engineering, specializing in Field Programmable Gate Arrays and Computer Vision. He earned his MBA from Harvard Business School and is a former executive at IBM. He has led multiple successful ventures and company exits to private equity. In 2018, Dan was named an Inc 500 CEO for his work on BoardVitals, a Medical Education company.

Greg Osmond, MD

Chief Medical Officer | Co-Founder

Gregory Osmond, MD, MPH is a board-certified pathologist and dermatopathologist. He completed pathology residency (AP/CP) at Duke University where he developed an interest and expertise in digital pathology while completing a GME concentration track in Health Policy, Law & Ethics focused on innovative business models and regulation associated with digital pathology. This was followed by dermatopathology fellowship in the combined Harvard program (MGH, B&W, BID). In recent years he has been involved with multiple pathology-related technology platforms and companies. He received a BS degree from Brigham Young University in Neuroscience, a Master degree in Public Health (MPH) from the University of Utah, and MD from Duke University. He also has a significant interest in the implementation and utilization of diagnostic services in underdeveloped settings.

Michael Torno

EVP Business Development | Co-Founder

Michael Torno has performed a variety of roles in the Life Sciences field. He previously served as the Senior Vice President of Global Clinical Healthcare Markets at Ascend Learning as well the General Manager of NursingCE. Mr. Torno has a BA from Kent State University in Psychology and an MA from the University of Akron in Industrial/Organizational Psychology. He spent the early stages of his career at Arthur Andersen in a business consulting role. In 2002, he immersed himself into the healthcare sector and joined Cerner Corporation. During his tenure at Cerner he relocated to Australia to help drive Cerner’s global expansion. Upon completion of his expatriate assignment, Mr. Torno became a partner in an infectious disease laboratory (Viracor Labs). During his tenure the laboratory grew exponentially, multiple assays were launched and robust operations were put in place. This laboratory continues to thrive today and is now owned by Eurofins Scientific.

April Larson, MD

Director of Clinical Implementation and Advisory Board

Dr. Larson received her medical degree from the University of Utah and completed a research fellowship at the Tom C. Mathews Familial Melanoma Research Clinic at Huntsman Cancer Institute. After dermatology residency at Dartmouth-Hitchcock Medical Center, she devoted herself to patient care for over 10 years. Through PathologyWatch, she sees digital pathology as key to improving dermatology diagnostics through the enhanced correlation of microscopic and clinical skin findings. As the Director of the Clinical Advisory Board and Clinical Implementation at PathologyWatch, she is focused on advancing patient care and access by delivering digital pathology and artificial intelligence solutions to dermatologists both nationally and globally.

Maren Chan, MD

Director of Laboratory Operations

Maren Chan, MD, MS is a board-certified dermatopathologist. She completed her residency and dermatopathology fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School. Her early career was spent as an active-duty Army dermatopathologist at San Antonio Military Medical Center. Thereafter, Dr. Chan was the medical director of an established primarily dermatology-trained dermatopathology laboratory in South Texas (Aurora Diagnostics/Sonic Healthcare). She received her BS in chemical engineering from Montana State University and MS in chemical engineering from the University of Washington, with an interest in mathematical modeling of airway gas exchange. Combining her experiences in laboratory operations, engineering, medical research, and high volume dermatopathology interpretation, she is excited to embark on this journey of large-scale implementation of digital pathology and artificial intelligence in medicine.